Latest in Cardiology from ACC.org

• Clinical Obesity Emerges as Independent Risk Factor For New-Onset HF, Mortality
  A cohort study published May 4 in JACC: Asia identified clinical obesity as a risk factor for new-onset heart failure (HF) and all-cause mortality, largely due to related clinical conditions and excess weight. Treating clinical obesity as an independent disease may increase the effectiveness of HF prevention strategies.
• ALLEPRE: Nurse-Coordinated Prevention Program May Reduce Long-Term CV Risk
  Implementing a nurse-coordinated prevention program (NCPP) significantly reduced long-term major adverse cardiovascular events (MACE) and improved body weight control, physical activity and pharmacotherapy adherence in post-hospitalization patients with acute coronary syndrome (ACS), according to results from the ALLEPRE trial published May 5 in EHJ.
• Rising HDP Rates in the US; BP Monitoring Across the Lifespan
  The rate of new-onset hypertensive disorders of pregnancy (HDP) in the U.S. increased significantly from 2016 to 2024 across all racial and ethnic groups, according to a brief JACC report – the importance of which is further echoed in a longer systematic review of blood pressure (BP) monitoring across a patient's lifespan published in JACC's […]
• Ivabradine vs. Propranolol For POTS; Testosterone Prescribing Trends
  Both ivabradine and propranolol reduced tachycardia and symptoms of postural orthostatic tachycardia syndrome (POTS), compared with placebo, based on findings from a randomized, double-blind crossover trial published in JACC and JACC: Advances.
•  Eagle’s Eye View: Can Rhythm Control Improve Tricuspid Regurgitation?
  In this week’s View, Dr. Eagle examines the role of rhythm control in improving moderate-to-severe and severe secondary tricuspid valve regurgitation.